Stockreport

SIGA Awarded Department of Defense Contract to Develop Expanded Indication for TPOXX® as Post-Exposure Prophylactic for Smallpox

SIGA Technologies Inc.  (SIGA) 
US:NASDAQ Investor Relations: investor.siga.com/investor-relations
PDF NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security mar [Read more]